Industry
Pharmaceuticals
Topic
All Topics
People
Find news about people
Organizations
Find news about organizations
Alumni
Find news on alumni of any org
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Pharmaceuticals
... billion in the first quarter, a sharper increase than analysts anticipated. Eli Lilly and—Up 1.4% : The pharmaceutical company boosted its full-year earnings projections after ...
... Pharmaceutical Co. on Tuesday made a fifth takeover proposal for rival drugmaker Shire PLC, a last-ditch move by the Japanese company that would likely value ...
... deal. U.K. consumer company Reckitt Benckiser Group PLC ended talks to buy Pfizer Inc.’s consumer-health business, which could fetch more than $10 billion, after the ...
... P.C.is conducting a securities investigation on behalf of investors of Prothena Corporation plc (NASDAQ: PRTA) to determine whether Prothena Corporation and certain of its officers ...
... and it's the perfect storm," said Mir Imran, Chairman & CEO of Rani Therapeutics. Imran continued, "There has never been a better time for innovation ...
... and capacity for additional speed and flexibility," said Jonathan Arnold, President of Catalent's Oral Drug Delivery business unit. "It is highly complementary to Catalent's West ...
... the deal toin-Pharma Technologist, saying: "Once the alliance is in effect, initially, Tilray capsules and ingestible oil products will be offered for sale under doctor's ...
... NightFood Holdings, Inc. (OTC: NGTF), Terra Tech Corp. (OTC: TRTC), Golden Leaf Holdings Ltd. (OTC: GLDFF) In a report by Benzinga, Viridian Capital President Scott ...
... proving to be a reliable choice for companies undertaking multi-center clinical trials. ProQR Therapeutics is the latest clinical research customer to choose SilhouetteStar and the ...
... Perrigo Company plc (NYSE; TASE: PRGO) today announced that it will release its first ...
... the potential activity and differentiation of our approach compared to first-generation ADCs." Valeant Pharmaceuticals Incorporated(NYSE: VRX) Developments: Bausch + Lomb, a leading global eye health ...
... DISSEMINATION IN THE UNITED STATES MONTREAL, April 24, 2018 (GLOBE NEWSWIRE) -- Pediapharm Inc. (the "Company" or "Pediapharm") (TSXV:PDP) (OTCQB:PDDPF) has been invited to present ...
... retail cannabis experience beyond the traditional dispensary vibe fits in nicely with Choom's clean, inviting retail concept. With a geographically diverse supply chain in the ...
... is currently the subject of the following ongoing litigations:Cosmo Technologies Limited, Valeant Pharmaceuticals International, and Valeant Pharmaceuticals Luxembourg S.A. R.L. v Lupin Ltd. and Lupin ...
... TraceLink Inc., the World's Largest Track and Trace Network for connecting the life ...
... Puration, Inc. (USOTC: PURA) today announced finalizing the terms with a Canadian cannabis grow operator for the acquisition of a business intended to expand ...
... Preliminary First Quarter 2018 Resultsand Earnings Announcement Date - China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated ...
... and is on the speaker's bureau for Abbott Diabetes Care, Astra Zeneca, Novo Nordisk Australia, Sanofi- Aventis, Eli Lilly and Company and Boehringer Ingelheim Pharmaceuticals. ...
... Janssen Pharmaceuticals, Hanmi Pharmaceuticals, Mannkind, Medtronic, Merck Sharp & Dohme Corp., Novartis, Novo Nordisk, Pfizer, Sanofi, Roche Diagnostics and UCB. Chantal Mathieu serves or has ...
... ESSA Pharma Inc. ("ESSA" or the "Company") (NASDAQ: EPIX, TSX-V: EPI), a pharmaceutical company focused on the development of novel small molecule drugs ...
... CytoSorbents Corporation(NASDAQ: CTSO), a critical care immunotherapy leader using itsCytoSorb®blood purification technology to treat ...
... is available here: Disclosure: Peter Adolfsson has received a research grant from Novo Nordisk and consulting fees associated with lectures/meetings from Eli Lilly, Novo Nordisk, ...
... Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) announced today that it will host a live webcast on ...
... Intec Pharma LTD (NASDAQ, TASE: NTEC) ("Intec" or "the Company") today announces that data ...
... Moleculin Biotech, Inc., (NASDAQ: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company focused ...
... Jeffrey Modell Foundation , a non-profit organization for primary immunodeficiency diseases, and X4 Pharmaceuticals , a clinical stage biotechnology company developing novel CXCR4 inhibitor drugs, ...
... free research to the investment community. Today we are offering reports on VCEL, VKTX, VTGN, and ZIOP which can be accessed for free by signing ...
... TORONTO, April 24, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. ("Golden Leaf" or the "Company") (CSE:GLH) (OTCQB:GLDFF), a leading cannabis oil ...
... Dystrophy (INAD) Presented LOS ALTOS, Calif., April 24, 2018 (GLOBE NEWSWIRE) -- Retrotope announced today positive findings from a compassionate use study of the company's ...
... and Manufacturing Agreements TUSTIN, Calif., April 24, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated contract development and manufacturing organization (CDMO) working ...
... RA'ANANA, Israel and NEW YORK, April 24, 2018 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq:URGN), a clinical-stage biopharmaceutical company developing treatments to address unmet needs ...
... United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will report its first quarter 2018 ...
... Recro Gainesville, LLC , a wholly owned subsidiary of Recro Pharma, Inc.,and a leading provider of solid oral dose manufacturing services for the ...
... Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, ...
... Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX VENTURE:TBP) (OTCQB:TBPMF), announced today that the ...
... AI genomics company Freenome today announces its partnership with leading proteomics company Biognosys to enhance its broad-signal approach to early-cancer detection and precision oncology. By ...
... TORONTO, April 24, 2018 (GLOBE NEWSWIRE) -- Nutritional High International Inc. (the "Company" or "Nutritional High") (CSE:EAT) (OTCQB:SPLIF) (FRANKFURT:2NU) is pleased ...
... DUBLIN, Ireland, April 24, 2018 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq:AVDL), today announced it will report its first quarter 2018 financial ...
... Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a research and development-focused biotechnology company dedicated to creating small ...
... Celgene Corporation(NASDAQ:CELG) today announced additional phase III data analyses evaluating the efficacy and ...
... Program to appropriately address the outstanding compliance issues that we inherited from Biotest Pharmaceuticals when we purchased the Boca facility, and we continue to generate ...
... Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions ...
... the assets returning from PGT and the OTC brands acquired primarily through Actavis in 2016.' PG President, Global Personal Health Care, Tom Finn, commented: 'The ...
... Indianapolis - Apexian Pharmaceuticals, a clinical-stage biotechnology company focused on developing safe and effective therapy ...
... immuno-oncology company, today announced that it has entered into an agreement with Incyte Corporation to expand their ongoing clinical trial collaboration. The Companies plan to ...
... the treatment setting WALTHAM, Mass., April 24, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced results from the QUADRA study, ...
... Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced new results from ...
... the execution of our research strategy." X-Biotix was recently launched out of X-Chem, a privately held biotechnology company focused on applying its unique DNA encoding ...
... Idorsia Pharmaceuticals Ltd. / Idorsia holds its first Annual General Meeting of Shareholders - ...
... Alpine Immune Sciences, Inc. (NASDAQ:ALPN) announced today the appointment of Chris Peetz to its Board ...
... Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering ...
... Fresenius and Akorn prepared to square off in court after the German company walked away ...
... Boston-based Vertex has faced challenges from governments in several countries about its drug prices. ...
... Wang previously served in leadership positions in clinical development and biometrics at Genentech and Geron.Dr. Uppal joins REVOLUTION Medicines from Medivation, where he led translational ...
... CANADIAN RESULTS THC Biomed Intl (CNSX:THC) reported loss for the quarter-ended 31 January 2018 of CAD9.3m ...
... CANADIAN RESULTS THC Biomed Intl (CNSX:THC), reported total revenue of CAD1.9m ($US1.6m) for the half year-ended ...
... announce the completion of a new £1.14 million investment in Wales-based ADC Biotechnology Ltd. ADC Biotechnology is creating innovative new technology, which aims to speed ...
... Paul set a target of $8.50, which exceeds the consensus of $7.06. KNIGHT THERAPEUTICS (GUD-TSX) CLOSE $8.14, UP 35¢ Knight Therapeutics Inc. presents investors with ...
... Systems, Inc (NASDAQ:CASS), William Lyon Homes (NYSE:WLH), AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG), Intersect ENT, Inc. (NASDAQ:XENT), and First Financial Bancorp. (NASDAQ:FFBC), including updated fundamental summaries, consolidated ...
... Uppsala, Sweden, April 24, 2018 - Oasmia Pharmaceutical AB hereby issues a notification regarding the issuance of the agenda for ...
... Connect Biopharmaceuticals, Ltd. today announced that it has submitted an application in Australia to ...
... top-line results still expected during 2020, in line with previous communication - PledPharma receives European patent approval for the composition of matter patent for PledOx(R) ...
... GNI USA, Inc., a wholly-owned subsidiary of GNI Group Ltd. (TOKYO:2160), announced the first subject was dosed in the F351 Phase ...
... 32.7p at 331.6p. Among the biggest fallers was FTSE 250 drug firm Vectura, where shares fell 11.05p to 87p as investors continued to digest news ...
... REPORT Corporate Wire Date: 23 April 2018 20:30 EDT ORIGINAL ANNOUNCEMENT [Text] Zymeworks Inc. (NYSE/TSX: ZYME), a clinical-stage biopharmaceutical company developing multifunctional therapeutics, today announced ...
... EDT ORIGINAL ANNOUNCEMENT [Text] VANCOUVER, April 23, 2018 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), plans to release its results ...
... Canadian Dollars ($) unless otherwise noted TORONTO, April 23, 2018 - PharmaCielo Ltd. ("PharmaCielo" or the "Company"), the Canadian parent of Colombia's largest and most ...
... OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, April 23, 2018 -- Emblem Corp. (TSXV:EMC) (EMC.WT) ("Emblem" or the "Company"), is pleased to announce that ...
... Corporate Wire Date: 23 April 2018 14:47 EDT ORIGINAL ANNOUNCEMENT [Text] Acerus Pharmaceuticals Corporation (TSX:ASP) ("Acerus" or the "Company") announced today that it has received ...
... Acquires Exclusive Canadian Rights to U.S. FDA-Approved A-101 40% Topical Solution from Aclaris Therapeutics MISSISSAUGA, ON, April 6, 2018 /CNW/ - Cipher Pharmaceuticals Inc. (TSX:CPH) ...
... has advised on some clear success stories for investors, notably pot stock Creso Pharma which is trading at more than triple its October 2016 listing ...
Subscribe now for full coverage on Pharmaceuticals
Start My Free Trial